FLOW trial: In participants with type 2 diabetes and chronic kidney disease, weekly semaglutide treatment substantially reduced risks of heart failure events or cardiovascular death. bit.ly/4g6UNBA #JACC #ESCCongress #HeartFailure #T2D #CKD #Semaglutide #CVD Richard Pratley MD

#JACC was proud to publish 5️⃣ of the 7️⃣ Late Breaking Science papers from STEP-HFpEF, SELECT, & FLOW, evaluating #semaglutide in CV, CKD, & #HeartFailure populations, ➕ effect on #COVID19. Explore our 🆕 #obesity site with commentary from Harlan Krumholz et al. on the Obesity

Nancy K Harlan Krumholz Gina Kolata The New York Times JACC Journals There are 5.6 million people in the US who match the inclusion criteria of the SELECT trial. If the mortality benefit detected here were replicated at that level, we'd have saved tens of thousands of lives. This is really important to consider.

#ESCCongress Day 1: the #ObesityRevolution has come to Cardiology, and JACC Journals is excited to launch a new special collection curating the latest science and clinical developments (1/10) jacc.org/special-collec… Harlan Krumholz Justine VarieurTurco American College of Cardiology #CardioTwitter

JACC Journals Harlan Krumholz Justine VarieurTurco American College of Cardiology Mikhail Kosiborod Subodh Verma Brigham and Women's Hospital Gina Kolata The New York Times Richard Pratley MD (10/10) And be sure to follow along on the JACC Journals website this weekend for the 🚨 **50** 🚨simultaneous publications in #JACC for #ESCCongress 2024! jacc.org/events/confere…

What a moment! The Lancet Editor richard horton and #JACC Editor Harlan Krumholz came together to celebrate the new partnership between the Journals. A rare opportunity for the two platforms to come together to improve CV care!

Beautiful venue for JACC Journals reception at #ESCCongress yesterday! Great opportunity to meet the leaders in #CVcare, Inspiring convos and thoughtful discussion. #Selfies of #ESCCongress

📽️ The Lancet Editor-in-Chief richard horton and #JACC Editor-in-Chief Harlan Krumholz unite to celebrate our new partnership. 🤝Our collaboration aims to improve global CV heath and ultimately reduce the global burden of cardiovascular disease.🌍❤️ More details:

Semaglutide, better known as Ozempic, "has far-reaching benefits beyond what we initially imagined," #JACC EiC Harlan Krumholz, said following the publication of several new studies at #ESCCongress. BBC reports on the new data: bbc.in/4e8QIvb

Congratulations to Dr. Rishi Wadhera on receiving 2 R01 grants totaling $6 million from the NIH for research focused on leveraging policy to advance cardiovascular health in United States.

Hospitals see more admissions for heart attacks in the days after ❄️cold weather❄️ sets in, new research published in JACC Journals and presented at #ESCCongress shows. HealthDay News reports: bit.ly/47cfoAD #JACC